Second Primary Malignancy in Multiple Myeloma: a retrospective monocentric analysis of Department of Hematology of the Oncologic Hospital from Cagliari
Retrospective analysis reveals second primary malignancies are common in multiple myeloma patients, suggesting a need for closer monitoring and management strategies.
Key Points
Forty-two patients (8.9%) developed at least one second primary malignancy, mostly solid tumors.
Patients treated with autologous stem cell transplantation had varied outcomes, highlighting the complexity of management.
Statistical analysis showed a significant difference in overall survival between hematologic malignancies and solid tumors.
The registry data provided crucial insights into treatment effects and long-term patient outcomes.